BioSpace News Archive

Implant Surfaces LLC and CMDC Labs have agreed to expand a joint development effort to pursue immunological and tissue integration research relating to machined and 3D-printed titanium implantable medical devices.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report third quarter 2022 financial results on Thursday, October 27, 2022.

This month, the University of Southern California’s Alzheimer’s Therapeutic Research Institute (ATRI) launched AlzMatch, a new research study where selected volunteers have their blood tested to determine potential eligibility for Alzheimer’s disease trials.

According to Nova one advisor, the global Healthcare Analytics market gathered revenue around USD 23.0 Billion in 2020 and market is set to grow USD 130.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 24.2% during the prediction period 2021 to 2027.

According to Nova one advisor, the global Healthcare API market was valued at USD 1.7 billion in 2021 and it is expected to hit around USD 2.0 billion by 2027 with a CAGR of 8.7% during the forecast period 2022 to 2027.

According to Nova one advisor, the global Healthcare Cloud Picture Archiving & Communications System market gathered revenue around USD 430.1 Million in 2020 and market is set to grow USD 1.02 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.9% during the prediction period 2021 to 2027.

Bionik Laboratories Corp . today announced the appointments of Richard Russo, Jr. as Chief Executive Officer and President, who previously served as Chief Financial Officer.

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that Company’s Management will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 6th Annual NASH Investor Conference.

DarioHealth Corp. announced that a mid-sized Midwestern city selected Dario to provide its full suite of digital therapeutics solutions to several thousand city employees beginning in the first quarter of 2023.

Horizon Therapeutics plc to Present New Data on TEPEZZA ® (teprotumumab-trbw) and Thyroid Eye Disease (TED) at the American Thyroid Association (ATA) Annual Meeting.